BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 34699139)

  • 1. Serum and follicular fluid chemerin and chemerin mRNA expression in women with polycystic ovary syndrome: Systematic review and meta-analysis.
    Mansoori A; Amoochi-Foroushani G; Zilaee M; Hosseini SA; Azhdari M
    Endocrinol Diabetes Metab; 2022 Jan; 5(1):e00307. PubMed ID: 34699139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian Expression of Adipokines in Polycystic Ovary Syndrome: A Role for Chemerin, Omentin, and Apelin in Follicular Growth Arrest and Ovulatory Dysfunction?
    Bongrani A; Mellouk N; Rame C; Cornuau M; Guérif F; Froment P; Dupont J
    Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31382403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High concentration of chemerin caused by ovarian hyperandrogenism may lead to poor IVF outcome in polycystic ovary syndrome: a pilot study.
    Wang Y; Huang R; Li X; Zhu Q; Liao Y; Tao T; Kang X; Liu W; Li S; Sun Y
    Gynecol Endocrinol; 2019 Dec; 35(12):1072-1077. PubMed ID: 31155988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating apelin and chemerin levels in patients with polycystic ovary syndrome: A meta-analysis.
    Gao Y; Xin C; Fan H; Sun X; Wang H
    Front Endocrinol (Lausanne); 2022; 13():1076951. PubMed ID: 36714603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of serum and follicular fluid chemerin concentrations during assisted reproductive cycles in women with polycystic ovary syndrome.
    Kabil Kucur S; Kurek Eken M; Sanli I; Kutlu T; Bilgic BE; Altuntas ŞL; Cevik O; Ozkaya E
    Gynecol Endocrinol; 2021 Sep; 37(9):814-818. PubMed ID: 34124981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased serum chemerin concentrations in patients with polycystic ovary syndrome: Relationship between insulin resistance and ovarian volume.
    Huang R; Yue J; Sun Y; Zheng J; Tao T; Li S; Liu W
    Clin Chim Acta; 2015 Oct; 450():366-9. PubMed ID: 26387454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemerin as a marker of body fat and insulin resistance in women with polycystic ovary syndrome.
    Kort DH; Kostolias A; Sullivan C; Lobo RA
    Gynecol Endocrinol; 2015 Feb; 31(2):152-5. PubMed ID: 25295622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating chemerin levels in women with polycystic ovary syndrome: a meta-analysis.
    Wang X; Zhang Q; Zhang L; Wei W; Liu L; Li B; Zhang L; Zhang Y; Hui Y; Lei Y
    Gynecol Endocrinol; 2022 Jan; 38(1):22-27. PubMed ID: 34402730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood Circulating Levels of Adipokines in Polycystic Ovary Syndrome Patients: A Systematic Review and Meta-analysis.
    Mehrabani S; Arab A; Karimi E; Nouri M; Mansourian M
    Reprod Sci; 2021 Nov; 28(11):3032-3050. PubMed ID: 34472034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of serum chemerin, vaspin and omentin-1 levels in patients with polycystic ovary syndrome.
    Guvenc Y; Var A; Goker A; Kuscu NK
    J Int Med Res; 2016 Aug; 44(4):796-805. PubMed ID: 27225862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated chemerin induces insulin resistance in human granulosa-lutein cells from polycystic ovary syndrome patients.
    Li X; Zhu Q; Wang W; Qi J; He Y; Wang Y; Lu Y; Wu H; Ding Y; Sun Y
    FASEB J; 2019 Oct; 33(10):11303-11313. PubMed ID: 31311314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of chemerin and CMKLR1 in the progesterone decrease by PCOS granulosa cells.
    Estienne A; Mellouk N; Bongrani A; Plotton I; Langer I; Ramé C; Petit C; Guérif F; Froment P; Dupont J
    Reproduction; 2021 Oct; 162(6):427-436. PubMed ID: 34605770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High androgen concentrations in follicular fluid of polycystic ovary syndrome women.
    Bongrani A; Plotton I; Mellouk N; Ramé C; Guerif F; Froment P; Dupont J
    Reprod Biol Endocrinol; 2022 Jun; 20(1):88. PubMed ID: 35701786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women?
    Yang S; Wang Q; Huang W; Song Y; Feng G; Zhou L; Tan J
    Gynecol Endocrinol; 2016; 32(1):38-41. PubMed ID: 26291816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased chemerin serum levels in hyperandrogenic and normoandrogenic women from Argentina with polycystic ovary syndrome.
    Abruzzese GA; Gamez J; Belli SH; Levalle OA; Mormandi E; Otero P; Graffigna MN; Cerrone GE; Motta AB
    Gynecol Endocrinol; 2020 Dec; 36(12):1057-1061. PubMed ID: 32496833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher levels of circulating chemerin in both lean and obese patients with polycystic ovary syndrome.
    Ademoglu E; Berberoglu Z; Carlioglu A; Dellal F; Gorar S; Alphan Z; Uysal S; Karakurt F
    Minerva Ginecol; 2014 Dec; 66(6):535-42. PubMed ID: 25373013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conventional GnRH antagonist protocols versus long GnRH agonist protocol in IVF/ICSI cycles of polycystic ovary syndrome women: a systematic review and meta-analysis.
    Kadoura S; Alhalabi M; Nattouf AH
    Sci Rep; 2022 Mar; 12(1):4456. PubMed ID: 35292717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations Between Serum Magnesium Concentrations and Polycystic Ovary Syndrome Status: a Systematic Review and Meta-analysis.
    Babapour M; Mohammadi H; Kazemi M; Hadi A; Rezazadegan M; Askari G
    Biol Trace Elem Res; 2021 Apr; 199(4):1297-1305. PubMed ID: 32812171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for masculinization of adipokine gene expression in visceral and subcutaneous adipose tissue of obese women with polycystic ovary syndrome (PCOS).
    Martínez-García MÁ; Montes-Nieto R; Fernández-Durán E; Insenser M; Luque-Ramírez M; Escobar-Morreale HF
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E388-96. PubMed ID: 23337724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Adipokine Levels in Nonobese Women With Polycystic Ovary Syndrome and in Nonobese Control Women: A Systematic Review and Meta-Analysis.
    Lin K; Sun X; Wang X; Wang H; Chen X
    Front Endocrinol (Lausanne); 2020; 11():537809. PubMed ID: 33488512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.